Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-24-005064
Filing Date
2024-11-14
Accepted
2024-11-14 15:11:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 cormorant-rapp093024a1.htm SC 13G/A 84647
  Complete submission text file 0001172661-24-005064.txt   86364
Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388
Cormorant Asset Management, LP (Filed by) CIK: 0001583977 (see all company filings)

EIN.: 462108927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215 857-321-8020
Rapport Therapeutics, Inc. (Subject) CIK: 0002012593 (see all company filings)

EIN.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-94532 | Film No.: 241460814
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)